PubHawk
Eur J Prev Cardiol July 2021 PMID 34298559

A scoring system for predicting individual treatment effects of statins in type 2 diabetes patients on haemodialysis.

Bernd Genser, Christoph Wanner, Winfried März

Full text PDF Download social card

Mentions

19
Peak: 12 in Aug 2021
across 4 sources since Mar 2020

Extended reach

332,038
potential audience

Total likes

68

Video views

3,374

Mentions per month

Mar 2020 – Jan 2026

Where it's discussed

  • X / Twitter14 posts
  • YouTube2 videos
  • Blogs2 articles
  • News1 articles

AI synopsis

What people are saying

The overall discussion demonstrates a genuine curiosity about the clinical implications of the scoring system, with phrases like 'potential impact' and 'personalized care' indicating a nuanced understanding. The tone varies from cautious optimism to recognition of risks, reflecting a balanced perspective on the study's significance.

AgreementModerate agreement

The discussion acknowledges the potential and relevance of the research, with some optimism about personalized care.

InterestModerate interest

Participants show a moderate interest, noting the importance of biomarkers and personalized treatment options.

EngagementModerate engagement

Tweets reflect thoughtful engagement, mentioning biomarkers, potential benefits, and risks involved.

ImpactNeutral impact

The conversation recognizes some potential impact, but also highlights uncertainties and the need for further validation.

Abstract in brief

  • Researchers developed a scoring system using specific patient markers to predict how individuals with type 2 diabetes on haemodialysis will respond to statin therapy, identifying those who may benefit, be neutral, or be harmed.
  • The study analyzed data from the 4D trial involving over 1,200 patients, creating two scores based on different sets of markers, which successfully stratified patients into groups with varying treatment effects and mortality outcomes.
  • The score incorporates markers linked to mechanisms like cholesterol metabolism and atherosclerosis, providing a potential clinical tool to personalize statin treatment, maximizing benefits while minimizing risks for haemodialysis patients.
Read the full abstract

Top posts

Most liked on X and Bluesky
European Society of Cardiology Journals
@ESC_Journals · X

Aug 29, 2021 · 29 likes · 12 shares · 117,046 followers View post →
Jochen Reiser MD PhD
@JochenReiser · X

Mar 1, 2020 · 8 likes · 4,694 followers View post →
European Society of Cardiology
@escardio · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 149,374 followers View post →
EHJ Editor-in-Chief
@ehj_ed · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 38,155 followers View post →
Silvia Castelletti
@SilCastelletti · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 8,680 followers View post →
CardioAcademic
@CardioAcademic · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 3,225 followers View post →

All mentions

Reira Espinosa
@reira_espinosa · X

RT @ESC_Journals:

Aug 30, 2021 · 12 shares · 191 followers View post →
Natsir Ramadhan
@natsiradhan · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 557 followers View post →
Silvia Castelletti
@SilCastelletti · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 8,680 followers View post →
Valentín Gallegos
@valenttin102 · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 144 followers View post →
Lavinia Baciu
@ESC_Lavinia · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 2,406 followers View post →
European Society of Cardiology
@escardio · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 149,374 followers View post →
CardioAcademic
@CardioAcademic · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 3,225 followers View post →
EHJ Editor-in-Chief
@ehj_ed · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 38,155 followers View post →
Alex Kharlamov MD FESC FACC FEACVI FAHA
@drskharlamov · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 1,670 followers View post →
DrMithilesh Nayak
@Dr_Mithilesh · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 213 followers View post →
Massimo Piepoli
@m_piepoli · X

RT @ESC_Journals:

Aug 29, 2021 · 12 shares · 1,645 followers View post →
European Society of Cardiology Journals
@ESC_Journals · X

Aug 29, 2021 · 29 likes · 12 shares · 117,046 followers View post →
Werner Leber
@WernerLeber · X

Potential impact of statins on people with diabetes on haemodialysis: - 1/3 benefit - 1/3 no effect - 1/3 may die Biomarkers could predict statin use for personalised care in the future. @schuler_jochen @DrAseemMalhotra @BritRenalSoc https://t.co/8BBnwQwoHU

Mar 5, 2020 · 347 followers View post →
Jochen Reiser MD PhD
@JochenReiser · X

Mar 1, 2020 · 8 likes · 4,694 followers View post →
Aktuelle Behandlungsstrategien für chronisch nierenkranke Patienten
News

... 10.1177/2047487320905721 (Epub ahead of print). 22. Mach F et al., Eur Heart J 2020, 41:111–188. 23. Koren JM, J Am Coll Cardiol 2019, 74:2132 ...

Dec 22, 2020 View →
<Erläuterungstext, Zusatzinformationen, Quellen>
Blogs

DOI: 10.1177/2047487320905721 https://doi.org/10.1177/2047487320905721. *Deutsche Diabetes Dialyse Studie (4D-. Studie). Randomized Controlled ...

Jun 17, 2020 View →
Welche Dialysepatienten profitieren von einer Behandlung mit ...
Blogs

https://doi.org/10.1177/2047487320905721. Bilder. Dialysepatienten haben ein hohes Risiko für Herz-Kreislauf-Erkrankungen < Dialysepatienten ...

Jun 17, 2020 View →